DR-189 Validating the Utility of Meta-Analysis for Learning Translatable Predictive Models from in vitro Pharmacogenomics
Several large initiatives have profiled cancer cell lines – lab grown models of disease – for their response to panels of drugs. These studies aim to identify genomic features that differentiate responders from non-responders. However, translating predictions back to patients has been challenging due to the differences between cell lines and patients, as well as experimental artifacts. We build upon previous work in integrating across studies from different labs to evaluate whether cross lab analysis results leads to better predictions. The genomic and treatment data collected by the Hartwig Foundation (HMF) will allow us to test predictions learned from cell lines.
Benjamin Haibe-Kains University Health Network Canada
Terug naar nieuwsMeer nieuws

Tussenstand GENAYA-project
In april 2022 is Hartwig Medical Foundation gestart met het GENAYA-project. Wat is de stand van zaken? Wat houdt GENAYA …

GenomeWeb: ‘Dutch Team Looks to Drug Repurposing to Improve Patient Outcomes, Lower Costs’
The project is an attempt to address the rising healthcare costs associated with new cancer drugs and to identify biomarkers …

DNA-analyse voor therapie op maat
27 februari 2019 Mensen met een minder voorkomende kankersoort en patiënten die zijn uitbehandeld komen mogelijk in aanmerking voor een …

Gegevens vastleggen en uitwisselen is essentieel voor goede zorg.